<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00552214</url>
  </required_header>
  <id_info>
    <org_study_id>ULT-001-TW1-Amendment 1.1</org_study_id>
    <nct_id>NCT00552214</nct_id>
  </id_info>
  <brief_title>Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens</brief_title>
  <official_title>Evaluation of a TMA Assay for the Screening of HIV-1 RNA, HCV RNA and HBV DNA in Human Blood Donor Plasma Specimens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to validate the performance characteristics of an assay that&#xD;
      tests for HIV-1, HCV and HBV on an automated blood bank instrument for registration&#xD;
      submission.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 8, 2007</start_date>
  <completion_date type="Actual">July 1, 2008</completion_date>
  <primary_completion_date type="Actual">July 1, 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and Specificity</measure>
    <time_frame>01 August 2007 to 31 December 2007</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10290</enrollment>
  <condition>Screening for the Presence of HIV-1, RNA and HBV DNA in Blood Donations</condition>
  <arm_group>
    <arm_group_label>Human Blood Donor Plasma Specimens</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Blood test</intervention_name>
    <description>Screening of HIV-1 RNA, HCV RNA and HBV DNA in Human Blood Donor Plasma Specimens</description>
    <arm_group_label>Human Blood Donor Plasma Specimens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  An acceptable blood donation health history and an EIA negative donation sample result&#xD;
             with licensed EIA procedures in routine use at each facility&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  A positive (reactive) HIV and/or HCV and/or HBV test&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Study Director</last_name>
    <role>Study Director</role>
    <affiliation>Grifols Biologicals, LLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Taipei Blood Center Taiwan Blood Service Foundation (TBSF)</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <link>
    <url>https://www.novctrd.com/ctrdweb/trialresult/trialresults/pdf?trialResultId=2615</url>
    <description>Novartis results database</description>
  </link>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>October 30, 2007</study_first_submitted>
  <study_first_submitted_qc>October 30, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2007</study_first_posted>
  <last_update_submitted>February 17, 2021</last_update_submitted>
  <last_update_submitted_qc>February 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nucleic acid test</keyword>
  <keyword>HIV-1</keyword>
  <keyword>hepatitis</keyword>
  <keyword>HBV</keyword>
  <keyword>HCV</keyword>
  <keyword>TMA</keyword>
  <keyword>HIV Seronegativity</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

